1-(2,6-Difluorophenyl)-3-(5-(5-(5,5-dimethyl-4-oxo-4,5-dihydroisoxazol-3-yl)-2-methylphenyl)pyrazin-2-yl)urea

ID: ALA4861030

PubChem CID: 164616569

Max Phase: Preclinical

Molecular Formula: C23H19F2N5O3

Molecular Weight: 451.43

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1ccc(C2=NOC(C)(C)C2=O)cc1-c1cnc(NC(=O)Nc2c(F)cccc2F)cn1

Standard InChI:  InChI=1S/C23H19F2N5O3/c1-12-7-8-13(19-21(31)23(2,3)33-30-19)9-14(12)17-10-27-18(11-26-17)28-22(32)29-20-15(24)5-4-6-16(20)25/h4-11H,1-3H3,(H2,27,28,29,32)

Standard InChI Key:  ZZAGUZPJLZUHOL-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 33 36  0  0  0  0  0  0  0  0999 V2000
   14.7524   -7.6677    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.0474   -8.0762    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0474   -8.8934    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.3383   -7.6677    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.6333   -8.0762    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6333   -8.8934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9242   -7.6677    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.9242   -9.3020    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.2152   -8.8934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2152   -8.0762    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5061   -9.3020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8011   -8.8934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0920   -9.3020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0920  -10.1192    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8011  -10.5278    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5061  -10.1192    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8011   -8.0762    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2097  -12.6024    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.4602  -11.8252    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.8011  -11.3450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1378  -11.8252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3925  -12.6024    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3606  -11.5705    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.5941  -12.7731    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4765  -13.4128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4614   -8.0762    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1705   -7.6677    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8796   -8.0762    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8796   -8.8934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1705   -9.3020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4614   -8.8934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7523   -9.3020    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   16.1705   -6.8505    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  5  6  1  0
  5  7  2  0
  6  8  2  0
  8  9  1  0
  9 10  2  0
  7 10  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 11 16  2  0
 12 17  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 18 22  1  0
 21 23  2  0
 22 24  1  0
 22 25  1  0
 15 20  1  0
  9 11  1  0
  4  5  1  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 26 31  2  0
 31 32  1  0
 27 33  1  0
  1 26  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4861030

    ---

Associated Targets(Human)

IL2 Tchem Interleukin-2 (144 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 451.43Molecular Weight (Monoisotopic): 451.1456AlogP: 4.46#Rotatable Bonds: 4
Polar Surface Area: 105.57Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 9.49CX Basic pKa: CX LogP: 5.05CX LogD: 5.04
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.61Np Likeness Score: -0.98

References

1. Khedkar NR, Irlapatti NR, Dadke D, Kanoje V, Shaikh Z, Karche V, Shinde V, Deshmukh G, Patil A, Jachak S, Phukan S, Kizhakinagath PA, Gholve M, Bhankhede T, Daler J, Nemade HN, Budhe S, Pareek H, Yeshodharan R, Gupta R, Kalia A, Pandey D, Wagh A, Kumar S, Patil V, Modi D, Sharma N, Ahirrao P, Mehta M, Kumar H, Nigade P, Tamane K, Mallurwar S, Kuldharan S, Pawar S, Vishwase G, Bokan S, Singh M, Naik K, Ingawale S, Shankar R, Kamalakannan P, Venugopal S, George SK, Padiya KJ, Nemmani KVS, Gundu J, Bhonde M, Narasimham L, Sindkhedkar M, Shah C, Sinha N, Sharma S, Bakhle D, Kamboj RK, Palle VP..  (2021)  Discovery of a Novel Potent and Selective Calcium Release-Activated Calcium Channel Inhibitor: 2,6-Difluoro-N-(2'-methyl-3'-(4-methyl-5-oxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)-[1,1'-biphenyl]-4-yl)benzamide. Structure-Activity Relationship and Preclinical Characterization.,  64  (23.0): [PMID:34843241] [10.1021/acs.jmedchem.1c01403]

Source